SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-265609
Filing Date
2021-09-03
Accepted
2021-09-03 16:58:02
Documents
12
Period of Report
2021-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d219315d8k.htm   iXBRL 8-K 26690
  Complete submission text file 0001193125-21-265609.txt   154027

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aadi-20210830.xsd EX-101.SCH 2885
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20210830_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20210830_pre.xml EX-101.PRE 11855
5 EXTRACTED XBRL INSTANCE DOCUMENT d219315d8k_htm.xml XML 3486
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 211237219
SIC: 2834 Pharmaceutical Preparations